期刊
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
卷 28, 期 2-3, 页码 155-161出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.beha.2015.10.013
关键词
Allo-HSCT; Bacteremia; Diversity; Intestinal microbiota; Microbial dominance; Metronidazole; Mortality; Survival
类别
资金
- NCI NIH HHS [P01 CA023766, P30 CA008748] Funding Source: Medline
- NIAID NIH HHS [K23 AI095398, R01 AI042135, R01 AI095706] Funding Source: Medline
While allogeneic hematopoietic stem cell transplantations have a curative potential, infections and graft-versus-host disease remain significant problems. The intestinal microbiota can influence responses to cancer chemotherapy and the role of the microbiota in affecting allogeneic hematopoietic stem cell transplantation outcomes is increasingly appreciated. The following paper discusses the most recent developments in this area. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
